Lataa...
Antibodies to watch in 2014
Since 2010, mAbs has documented the biopharmaceutical industry’s progress in transitioning antibody therapeutics to first Phase 3 clinical studies and regulatory review, and its success at gaining first marketing approvals for antibody-based products. This installment of the “Antibodies to watch” se...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3929455/ https://ncbi.nlm.nih.gov/pubmed/24284914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.27333 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|